OLD National Bancorp IN Lowers Stock Position in CVS Health Corporation $CVS

OLD National Bancorp IN cut its stake in shares of CVS Health Corporation (NYSE:CVS) by 5.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 328,660 shares of the pharmacy operator’s stock after selling 18,955 shares during the quarter. OLD National Bancorp IN’s holdings in CVS Health were worth $26,082,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Sei Investments Co. grew its position in CVS Health by 17.4% in the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock worth $62,474,000 after acquiring an additional 134,535 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock valued at $77,353,000 after purchasing an additional 13,329 shares in the last quarter. Treasurer of the State of North Carolina lifted its stake in CVS Health by 1.3% during the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock worth $40,358,000 after purchasing an additional 7,588 shares during the last quarter. HUB Investment Partners LLC boosted its holdings in shares of CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock worth $1,039,000 after purchasing an additional 3,011 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in shares of CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock worth $111,017,000 after purchasing an additional 119,439 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS opened at $77.21 on Thursday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The stock’s 50 day simple moving average is $76.01 and its 200 day simple moving average is $77.84. The firm has a market cap of $98.95 billion, a price-to-earnings ratio of 55.98, a PEG ratio of 0.81 and a beta of 0.51. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. During the same quarter in the prior year, the firm posted $1.19 earnings per share. The business’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts predict that CVS Health Corporation will post 7.14 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio is currently 192.75%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CVS. The Goldman Sachs Group raised their price objective on CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Sanford C. Bernstein upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and increased their price target for the company from $91.00 to $94.00 in a research report on Thursday, March 12th. Leerink Partners restated an “outperform” rating and issued a $98.00 price objective on shares of CVS Health in a report on Thursday, March 5th. Argus cut their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Finally, Wolfe Research reduced their target price on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a report on Monday, March 2nd. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $95.05.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Recent operating results and outlook support upside: analysts point to CVS’s Q4 beat, year?over?year revenue growth and management’s FY?2026 EPS guidance, giving some investors confidence in the company’s turnaround and value proposition. Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
• Positive Sentiment: Longer?term value case: recent commentary argues CVS looks attractively valued if its Optum-like integration and retail/primary care initiatives gain traction, which supports buy?and?hold investors. Is CVS Health the Ultimate Value Stock to Buy Right Now?
• Neutral Sentiment: Sector dynamics: UnitedHealth’s stronger guidance and ongoing debates over coverage for expensive obesity drugs are reshaping payer/provider economics; these broader moves can influence CVS’s PBM/insurer peers and competitive positioning but are not company?specific catalysts. UnitedHealth Boosts Profit Forecast Without Committing to Medicare Obesity Drug Coverage
• Negative Sentiment: State regulatory risk — Tennessee passed a bill targeting pharmacy ownership of PBMs; the law could force structural changes and has prompted CVS to warn it may close stores and pursue litigation, creating revenue, margin and execution uncertainty in a meaningful regional market. Legislation to ban pharmacies from owning PBMs heads to Gov. Lee’s desk, CVS Health may close Tenn. locations
• Negative Sentiment: CVS warns store closures and legal fight: management has publicly said the Tennessee law could lead to ~100 store closures and plans to challenge the statute in court — a short?term cost and reputation headwind that investors view as downside risk. Tennessee passes crackdown on pharmacy middlemen; CVS warns 100 stores could close, vows court fight
• Negative Sentiment: Primary care deal economics: reports indicate the Mass General Brigham partnership could raise annual care spending by roughly $40M, suggesting the company’s primary?care expansion may carry larger near?term cost pressure than modeled. Mass General Brigham, CVS Primary Care Deal Could Have a $40M Hidden Cost of Access

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.